A Targeted Approach to Bladder Cancer Management
Bladder cancer, particularly the aggressive muscle-invasive type, often requires systemic chemotherapy. Doxorubicin, part of standard regimens like MVAC (with methotrexate, vinblastine, cisplatin), has been effective but faces challenges like toxicity and resistance. By 2026, innovations specific to bladder cancer—such as localized delivery...
Turkish 
English
Arabic
French
Spanish
Portuguese
Deutsch
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Tiếng Việt